These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

542 related items for PubMed ID: 17963210

  • 1. Synthesis and activity of a trinuclear platinum complex: [{trans-PtCl(NH3)2}2mu-{trans-Pt(3-hydroxypyridine)2(H2N(CH2)6NH2)2}]Cl4 in ovarian cancer cell lines.
    Tayyem H, Huq F, Yu JQ, Beale P, Fisher K.
    ChemMedChem; 2008 Jan; 3(1):145-51. PubMed ID: 17963210
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Synthesis, characterization, activities, cell uptake and DNA binding of trinuclear complex: [{trans-PtCl(NH(3))}(2)mu-{trans-Pt(NH(3))(2-hydroxypyridine)-(H(2)N(CH(2))(6)NH(2))(2)]Cl(4).
    Cheng H, Huq F, Beale P, Fisher K.
    Eur J Med Chem; 2005 Aug; 40(8):772-81. PubMed ID: 16122580
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Synthesis of trans-bis-(2-hydroxypyridine)dichloroplatinum(II) and its activity in human ovarian tumour models.
    Deqnah N, Yu JQ, Beale P, Fisher K, Huq F.
    Anticancer Res; 2012 Jan; 32(1):135-40. PubMed ID: 22213298
    [Abstract] [Full Text] [Related]

  • 7. Studies on synthesis, activity and binding with DNA of a new trinuclear platinum compound [{trans-PtCl(NH3)2}2{trans-Pt(thiazole)2}{H2N(CH2)(6NH2}2]Cl3(NO3).
    Al-Shuneigat J, Qing Y, Beale P, Fisher K, Huq F.
    Med Chem; 2011 Jan; 7(1):1-8. PubMed ID: 21235513
    [Abstract] [Full Text] [Related]

  • 8. Synthesis, activity and binding with DNA of [{trans-PtCl(NH(3))(2)}(2)micro-{trans-Pd(4-hydroxypyridine) (2) (H(2)N(CH(2))(6)NH(2))(2)]Cl(4) (TH8).
    Huq F, Tayyem H, Yu JQ, Beale P, Fisher K.
    Med Chem; 2009 Jul; 5(4):372-81. PubMed ID: 19689395
    [Abstract] [Full Text] [Related]

  • 9. Studies on the activity of two Trans-planaramine platinum(II) complexes coded as DH4 and DH5 in human ovarian tumour models.
    Deqnah N, Yu JQ, Beale P, Huq F.
    Anticancer Res; 2012 Dec; 32(12):5331-6. PubMed ID: 23225434
    [Abstract] [Full Text] [Related]

  • 10. Synthesis of a monofunctional platinum compound and its activity alone and in combination with phytochemicals in ovarian tumor models.
    Arzuman L, Beale P, Yu JQ, Proschogo N, Huq F.
    Anticancer Res; 2014 Dec; 34(12):7077-90. PubMed ID: 25503135
    [Abstract] [Full Text] [Related]

  • 11. Studies on activities, cell uptake and DNA binding of four trans-planaramineplatinum(II) complexes of the form: trans-PtL(NH3)Cl2, where L=2-hydroxypyridine, imidazole, 3-hydroxypyridine and imidazo(1,2-alpha)pyridine.
    Huq F, Yu JQ, Daghriri H, Beale P.
    J Inorg Biochem; 2004 Aug; 98(8):1261-70. PubMed ID: 15271501
    [Abstract] [Full Text] [Related]

  • 12. Studies on activities, cell up take and DNA binding of four multinuclear complexes of the form: [[trans-PtCl(NH(3))(2)](2)mu-[trans-Pd(NH(3))(2)-(H(2)N(CH(2))(n)NH(2))(2)]]Cl(4) where n=4-7.
    Daghriri H, Huq F, Beale P.
    J Inorg Biochem; 2004 Nov; 98(11):1722-33. PubMed ID: 15522400
    [Abstract] [Full Text] [Related]

  • 13. Studies on the synthesis and activity of three tripalladium complexes containing planaramine ligands.
    Farhad M, Yu JQ, Beale P, Fisher K, Huq F.
    ChemMedChem; 2009 Nov; 4(11):1841-9. PubMed ID: 19746359
    [Abstract] [Full Text] [Related]

  • 14. Studies of interaction of trichloro{eta2-cis-N,N-dimethyl-1-[6-(N',N'-dimethyl-ammoniummethyl)-cyclohex-3-ene-1-yl]-methylammonium}platinum(II) chloride with DNA: Effects on secondary and tertiary structures of DNA. Cytotoxic assays on human ovarian cancer cell lines, resistant and non-resistant to cisplatin.
    Gay M, Montaña AM, Moreno V, Prieto MJ, Pérez JM, Alonso C.
    Bioorg Med Chem; 2006 Mar 01; 14(5):1565-72. PubMed ID: 16256352
    [Abstract] [Full Text] [Related]

  • 15. Synergism from combination of cisplatin and a trans-platinum compound in ovarian cancer cell lines.
    Alshehri A, Beale P, Yu JQ, Huq F.
    Anticancer Res; 2010 Nov 01; 30(11):4547-53. PubMed ID: 21115904
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and activity of [{Cis-PtCl(NH3)2}2µ{trans-Pt(3-Hydroxypyridine)2(H2N(CH2)6NH2)2}]Cl4 in the human ovarian tumour models.
    Hamad SA, Beale P, Yu JQ, Fisher K, Huq F.
    Med Chem; 2012 May 01; 8(3):384-91. PubMed ID: 22530892
    [Abstract] [Full Text] [Related]

  • 17. Studies on two new mixed ligand platinum compounds with a trans-geometry.
    Al-Shuneigat J, Yu JQ, Beale P, Fisher K, Huq F.
    Med Chem; 2010 Sep 01; 6(5):321-8. PubMed ID: 20977416
    [Abstract] [Full Text] [Related]

  • 18. Studies on combinations of platinum with paclitaxel and colchicine in ovarian cancer cell lines.
    Yunos NM, Beale P, Yu JQ, Strain D, Huq F.
    Anticancer Res; 2010 Oct 01; 30(10):4025-37. PubMed ID: 21036717
    [Abstract] [Full Text] [Related]

  • 19. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W, Chaney SG.
    Cancer Res; 1993 Feb 15; 53(4):799-805. PubMed ID: 8428361
    [Abstract] [Full Text] [Related]

  • 20. Synthesis of trans-(4-hydroxypyridine)(ammine)dichloroplatinum(II) and its activity in the human ovarian tumour models.
    Deqnah N, Qing Yu J, Beale P, Fisher K, Huq F.
    Med Chem; 2013 Jun 01; 9(4):539-44. PubMed ID: 23061563
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.